MRNA vs LLY
AI-powered head-to-head comparison · Updated September 11, 2026
Factor Comparison
| Factor | MRNA | LLY | Winner |
|---|---|---|---|
| Overall Score | 100 | 58 | MRNA |
| Composite Momentum | +264.7% | +17.7% | MRNA |
| Relative Strength | +180.7% | -5.2% | MRNA |
| 20-Day Momentum | +126.7% | -8.7% | MRNA |
| RSI-14 | 35.6 | 7.9 | MRNA |
| Volatility | 626.1% | 29.6% | LLY |
Based on TradeWise's 6-factor AI model, MRNA currently scores higher. Both stocks are in the Health Care sector. The current market regime is CHOPPY.
Get AI-powered trading signals
4 AI agents debate every trade. 6-factor scoring. Regime-adaptive risk management. 14-day free trial, no credit card.
Start Free Trial →
Disclaimer: TradeWise provides AI-generated analysis for educational purposes only. This is not financial advice.
Past performance does not guarantee future results. All investing involves risk of loss. Backtested results are hypothetical.
Consult a qualified financial adviser before making investment decisions. Scores generated by the V56 momentum engine
based on Jegadeesh & Titman (1993) momentum research and Barroso & Santa-Clara (2015) volatility targeting.